Elixirgen Therapeutics's last reported valuation, Nov 2023. Nothing priced has surfaced since.
Valuation timeline
0 priced rounds · 60 daily marks since · Sep 2026 – Nov 2026Membership and data by Private Market View
Elixirgen Therapeutics funding history
8 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2025 | Seed Round | $4.0M | ▮ | ▮ |
| Mar 2025 | Seed Round | $3.6M | ▮ | ▮ |
| Jan 2025 | Seed Round | $600K | ▮ | ▮ |
| Nov 2023 | Early Stage VC | $7.0M | ▮ | ▮ |
| Sep 2022 | Debt | $5.0M | ▮ | ▮ |
| Feb 2021 | Seed Round | $4.2M | ▮ | ▮ |
| + 2 earlier rounds · a free Private Market View account shows the full history | ||||
Membership and data by Private Market View
Elixirgen Therapeutics valuation
Elixirgen Therapeutics's last reported valuation was $67 million in Nov 2023. No priced round, secondary trade or fund mark has surfaced since.
How much has Elixirgen Therapeutics raised?
Elixirgen Therapeutics has raised $29.1 million across 8 recorded rounds since 2018. The largest was a $7 million early-stage round in Nov 2023; the most recent was a $4 million seed round in Oct 2025.
Elixirgen Therapeutics has filed 9 Form Ds with the SEC since 2018, most recently in Nov 2025 ($4 million sold to 1 investor).
How Elixirgen Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Elixirgen Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Elixirgen Therapeutics
- What is Elixirgen Therapeutics worth?
- Elixirgen Therapeutics is valued at $67.0M as of Nov 2026. Elixirgen Therapeutics's last reported valuation, Nov 2023. Nothing priced has surfaced since.
- How much has Elixirgen Therapeutics raised?
- Elixirgen Therapeutics has raised $29.1M in total funding across 8 recorded rounds.
- When did Elixirgen Therapeutics last raise?
- Elixirgen Therapeutics last raised in Oct 2025 (Seed Round), raising $4.0M.